{"id":67851,"date":"2017-07-02T19:30:39","date_gmt":"2017-07-02T17:30:39","guid":{"rendered":"https:\/\/new.vetom.club\/for-oncological-patients\/"},"modified":"2018-03-28T14:57:33","modified_gmt":"2018-03-28T12:57:33","slug":"for-oncological-patients","status":"publish","type":"page","link":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/","title":{"rendered":"For oncological patients"},"content":{"rendered":"<h3>For oncological patients<\/h3>\n<p style=\"text-align: justify;\">Vetom is a recommended supportive therapy for patients with cancer and malignant tumors.<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff0000;\"><strong>For oncological patients, Vetom 1.1 or 1.23 is recommended for immune activation.<\/strong> <strong><br \/>\nThese preparations recover the immune system after surgery, radiotherapy and chemotherapy, reduce the toxic effects during and after treatment.<\/strong> <strong>At the same time, they act as a stimulant of hematopoiesis in oncological diseases and contribute in increasing the effect of medications.<\/strong><\/span><\/p>\n<h3 style=\"text-align: justify;\"><strong>Vetom instantly strengthens the human immune system and helps to cope with \u00a0serious illnesses. <\/strong><\/h3>\n<p style=\"text-align: justify;\">The Bacillus subtilis bacteria contained in Vetom 1.1 and Vetom 1.23 multiply in the intestines biologically active substances, which suppress the growth and development of pathogenic and conditionally pathogenic microflora and various types of staphylococcus and streptococcus. As a result of this process, the intestinal microflora is normalized, the walls of the digestive tract are cleansed from indigestible and rotting food residues, which supports the removal of toxins from the body.<\/p>\n<p style=\"text-align: justify;\">After this process, the body is more effectively prepared to absorb biologically active substances and nutrients. The action of Bacillus subtilis improves the absorption and metabolism of iron, calcium, fats, proteins, carbohydrates, triglycerides, amino acids, dipeptides, sugars, salts of bile acids and a balanced pH of the gastrointestinal tract.<br \/>\nBy regular use of the product, the body gradually becomes resistant to attacks of harmful bacteria and viruses.<\/p>\n<p style=\"text-align: justify;\"><strong>Only the Bacillus subtilis bacteria contained in Vetom 1.1 and Vetom 1.23 are capable of <\/strong><a href=\"https:\/\/translate.googleusercontent.com\/translate_c?depth=1&amp;hl=cs&amp;rurl=translate.google.cz&amp;sl=cs&amp;sp=nmt4&amp;tl=en&amp;u=https:\/\/www.vetom.club\/slovnicek-pojmu\/&amp;usg=ALkJrhhIQimOBRwl99EQEDyL1mr46BTEZw#interferon\"><strong>producing interferon <\/strong><\/a><strong><u>,<\/u><\/strong><strong> which actively prevents the reproduction of viruses and refers to infected cells in the organism, creating antitumor and immune-stimulating activities.<\/strong><\/p>\n<h3 style=\"text-align: justify;\"><strong>Interferon alpha-2-leukocyte human<\/strong><\/h3>\n<p style=\"text-align: justify;\">&#8211; produced by Bacillus subtilis bacteria enters the bloodstream through the walls of the digestive tract, suppresses cellular viral infection, alters cell membrane ectoplast, prevents adhesion and penetration of virus into the cell. It initiates the synthesis of a number of specific ferments, disrupting the synthesis of viral RNA (RNA) and viral proteins in the cell.<\/p>\n<p style=\"text-align: justify;\">It modifies the cytoskeleton of the cell membrane, prevents the proliferation (proliferation, abundant proliferation, and the formation of neoplasms) of cancer cells. It acts on the synthesis of some oncogenes and inhibits (slows down or stops) tumor growth. It stimulates the activity of so-called &#8220;nk killers&#8221; that are part of antiviral immunity.<\/p>\n<p style=\"text-align: justify;\">All anti-tumor effects of interferon are divided into direct and indirect. The direct ones have the ability to suppress the growth of tumor cells. The indirect ones are associated with enhancing the ability of immune cells to detect and destroy abnormal cells in the body, ensuring optimal functioning of the immune system.<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff0000;\"><strong>For oncological patients, the first treatment effect begins after 10 days of use.<\/strong> <\/span><strong><br \/>\n<\/strong>This is associated with the fact that after 10 days of use of the preparation, the concentration of so called \u201enk killer\u201c cells is multiplied in the blood. To healthy people this can rarely lead to autoimmune reaction. For patients with oncological diseases, on the contrary, this effect is highly desirable and the curative effect of \u201enk killers\u201c after 10 days of use of the preparation primarily destroys the cancer cells.<\/p>\n<h3 style=\"text-align: justify;\"><strong>Recommended Vetom Cure 1.1. <\/strong><\/h3>\n<p style=\"text-align: justify;\">Supplemental therapy for oncological patients in capsule form lasts for 30 days. Recommended dosage is 10 capsules a day.<br \/>\nVetom 1.1 can be re-taken 2 months after the end of use.<br \/>\nAfter a 10-14 day break,\u00a0 Vetom 4, 10 capsules a day.<br \/>\nAfter a 10-14 day break, Vetom 3, 10 capsules a day.<br \/>\nAfter a 10-14 day break,\u00a0 Vetom 2, 1 capsule in the morning and 1 capsule in the evening.<\/p>\n<h3 style=\"text-align: justify;\"><strong>Recommended cure for Vetom 1.23 <\/strong><\/h3>\n<p style=\"text-align: justify;\">Supplemental therapy for oncological patients in liquid form lasts 30 days. 1 drop of preparation means one dose. 10 drops per day are recommended.<br \/>\nVetom 1.23 can then be re-taken 2 months after the end of use.<br \/>\nAfter a 10-14 day break, Vetom 4, 10 capsules a day.<br \/>\nAfter a 10-14 day break, Vetom 3, 10 capsules a day.<br \/>\nAfter a 10-14 day break, Vetom 2, 1 capsule in the morning and 1 capsule in the evening.<\/p>\n<h3 style=\"text-align: justify;\"><strong>VETOM Clinical Test Report on Cancer Patients <\/strong><\/h3>\n<p style=\"text-align: justify;\">Evaluation of the efficacy of the Interferon bacterium, which produces VETOM 1.1 as a supportive therapy for patients with malignant tumors. A total of 65 patients were monitored. Most patients were taken into the test during a metastatic disease after previous integrated or combined treatment. All patients in the group were asked for symptomatic treatment and were denied special treatment.<br \/>\nPatients are in the stage 4 \u2013 IV. clinical group. All patients underwent chemotherapy. After being released from the hospital to increase their antitumor resistance, patients were given VETOM 1.1 &#8211; 1 tablet 10 times a day, 10-15 minutes before meal, for 30 days.<br \/>\nAfter 1-1.5 months, the patients came back to review and continue the treatment &#8211; chemotherapy including hyperthermia. After discharging from the hospital, they continued using VETOM 1.1 as before.<br \/>\nObservations were conducted for over 2 years, and patients were treated with 1 to 8 Vetom 1.1 series.<\/p>\n<p style=\"text-align: justify;\">After treatment with VETOM 1.1, the total serum protein level was significantly increased and returned to normal range. There was also a decrease in ALT and AST transaminases by 32.6 and 28.5%. This may indicate protein recovery and antitoxic liver function.<br \/>\nWithin 7 to 10 days after the end of chemotherapy, the overal health status improved, the patients registered: sleep improvement, stool normalization, improvement of hair loss,\u00a0 weight gain 3.4 kg during 2-3 months.<\/p>\n<p style=\"text-align: justify;\">The analysis made it possible to identify indications for using VETOM 1.1 and VETOM 3.<br \/>\nRecovery of balanced microflora and supplementation of natural immunostimulants to the human body after surgery, radiotherapy and chemotherapy.<\/p>\n<p style=\"text-align: justify;\">Reduction of toxic effects during and after chemotherapy and maintenance of immunotherapy between cycles of chemotherapy.<br \/>\nProtective effect in metastatic liver lesions of concomitant chronic hepatitis B and C, liver cirrhosis.<br \/>\nImmunotherapy for some types of cancers: kidney, bladder, skin, colon, melanoma, lymphoma.<\/p>\n<p style=\"text-align: justify;\">This means that the bacterial preparation VETOM 1.1, producing the interferon immunostimulant and VETOM 3, can be used as a prophylactic treatment to reduce the toxic effects of chemotherapy and radiation therapy, it also has regenerative and detoxifying effects and an effect on restoring the antitumor activity of the organism.<\/p>\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>For oncological patients Vetom is a recommended supportive therapy for patients with cancer and malignant tumors. For oncological patients, Vetom 1.1 or 1.23 is recommended for immune activation. These preparations recover the immune system after surgery, radiotherapy and chemotherapy, reduce the toxic effects during and after treatment. At the same time, they act as a &#8230; <a title=\"For oncological patients\" class=\"read-more\" href=\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\" aria-label=\"Read more about For oncological patients\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":69562,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-67851","page","type-page","status-publish","has-post-thumbnail"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.7 (Yoast SEO v25.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Currative Vetom therapy for oncological patients<\/title>\n<meta name=\"description\" content=\"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"For oncological patients\" \/>\n<meta property=\"og:description\" content=\"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"VETOM Club\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Vetom-Club-1823484797939610\/\" \/>\n<meta property=\"article:modified_time\" content=\"2018-03-28T12:57:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\",\"url\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\",\"name\":\"Currative Vetom therapy for oncological patients\",\"isPartOf\":{\"@id\":\"https:\/\/www.vetom.club\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png\",\"datePublished\":\"2017-07-02T17:30:39+00:00\",\"dateModified\":\"2018-03-28T12:57:33+00:00\",\"description\":\"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage\",\"url\":\"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png\",\"contentUrl\":\"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Vetom Club\",\"item\":\"https:\/\/www.vetom.club\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For oncological patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vetom.club\/en\/#website\",\"url\":\"https:\/\/www.vetom.club\/en\/\",\"name\":\"VETOM Club\",\"description\":\"Revolutionary immune activator on a natural basis\",\"publisher\":{\"@id\":\"https:\/\/www.vetom.club\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vetom.club\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vetom.club\/en\/#organization\",\"name\":\"Vetom Club\",\"url\":\"https:\/\/www.vetom.club\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vetom.club\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.vetom.club\/wp-content\/uploads\/2017\/11\/vetom-club-logo-1.png\",\"contentUrl\":\"https:\/\/www.vetom.club\/wp-content\/uploads\/2017\/11\/vetom-club-logo-1.png\",\"width\":270,\"height\":60,\"caption\":\"Vetom Club\"},\"image\":{\"@id\":\"https:\/\/www.vetom.club\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Vetom-Club-1823484797939610\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Currative Vetom therapy for oncological patients","description":"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/","og_locale":"en_US","og_type":"article","og_title":"For oncological patients","og_description":"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.","og_url":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/","og_site_name":"VETOM Club","article_publisher":"https:\/\/www.facebook.com\/Vetom-Club-1823484797939610\/","article_modified_time":"2018-03-28T12:57:33+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_description":"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/","url":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/","name":"Currative Vetom therapy for oncological patients","isPartOf":{"@id":"https:\/\/www.vetom.club\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png","datePublished":"2017-07-02T17:30:39+00:00","dateModified":"2018-03-28T12:57:33+00:00","description":"We recommend Vetom 1.1 or 1.23 as suplementary therapy for oncological patients to activate the immunity. Preparations reduce toxic effects during and after treatment.","breadcrumb":{"@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vetom.club\/en\/for-oncological-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#primaryimage","url":"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png","contentUrl":"https:\/\/www.vetom.club\/wp-content\/uploads\/2018\/03\/princip-ucinku-preparatu-Vetom.png","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/www.vetom.club\/en\/for-oncological-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Vetom Club","item":"https:\/\/www.vetom.club\/en\/"},{"@type":"ListItem","position":2,"name":"For oncological patients"}]},{"@type":"WebSite","@id":"https:\/\/www.vetom.club\/en\/#website","url":"https:\/\/www.vetom.club\/en\/","name":"VETOM Club","description":"Revolutionary immune activator on a natural basis","publisher":{"@id":"https:\/\/www.vetom.club\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vetom.club\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vetom.club\/en\/#organization","name":"Vetom Club","url":"https:\/\/www.vetom.club\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vetom.club\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.vetom.club\/wp-content\/uploads\/2017\/11\/vetom-club-logo-1.png","contentUrl":"https:\/\/www.vetom.club\/wp-content\/uploads\/2017\/11\/vetom-club-logo-1.png","width":270,"height":60,"caption":"Vetom Club"},"image":{"@id":"https:\/\/www.vetom.club\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Vetom-Club-1823484797939610\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/pages\/67851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/comments?post=67851"}],"version-history":[{"count":0,"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/pages\/67851\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/media\/69562"}],"wp:attachment":[{"href":"https:\/\/www.vetom.club\/en\/wp-json\/wp\/v2\/media?parent=67851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}